Cancer Chemotherapy and Pharmacology
 | This article needs additional citations for verification. (August 2018) |
 | |
| Discipline | Pharmacology, oncology |
|---|---|
| Language | English |
| Edited by | Jan Hendrik Beumer and Étienne Chatelut |
| Publication details | |
| History | 1978-present |
| Publisher | Springer Science+Business Media (Germany) |
| Frequency | Monthly |
| 3.333 (2020) | |
| Standard abbreviations | |
| ISO 4 | Cancer Chemother. Pharmacol. |
| Indexing | |
| CODEN | CCPHDZ |
| ISSN | 0344-5704 (print) 1432-0843 (web) |
| OCLC no. | 04084336 |
| Links | |
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are Jan Hendrik Beumer (University of Pittsburgh School of Pharmacy) and Étienne Chatelut (Institut Claudius-Regaud). According to the Journal Citation Reports, the journal has a 2020 impact factor of 3.333.[1]
References[edit]
- ^ "Cancer Chemotherapy and Pharmacology". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2021.
External links[edit]
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
 | This article about an oncology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |